Finn H Andresen

Title: The Innovations of Finn H Andresen

Introduction

Finn H Andresen is a notable inventor based in Hillerod, Denmark. He has made significant contributions to the field of therapeutic insulin preparation. With a total of 2 patents, his work has had a profound impact on diabetes treatment.

Latest Patents

Andresen's latest patents include a process for preparing human insulin or B-30 esters thereof. This innovative method focuses on creating novel stable insulin preparations with protracted action and reduced or no antigenicity. The process involves reacting insulin free of antigenic impurities with an organic compound that has basic amino groups, preferably a basic polypeptide or a cleavage product of a basic polypeptide, such as protamine. This reaction occurs in a buffered protein dissociating or protein depolymerizing aqueous medium. Preferred media for this process include aqueous solutions containing urea, a lower alkanol dialkylformamide, acetamide, N-alkyl-acetamide, or acetonitrile.

Career Highlights

Finn H Andresen is associated with Nordisk Insulinlaboratorium, a company renowned for its advancements in insulin production. His work has been pivotal in enhancing the efficacy and safety of insulin therapies for patients.

Collaborations

Andresen has collaborated with notable colleagues such as Bruno A Hansen and Per Balschmidt. Their combined expertise has contributed to the success of various projects in the field of insulin research.

Conclusion

Finn H Andresen's innovative work in insulin preparation showcases his dedication to improving diabetes treatment. His patents reflect a commitment to advancing medical science and enhancing patient care.